NCT04641078View on ClinicalTrials.gov

Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

February 12, 2021

Primary Completion Date

February 12, 2026

Study Completion Date

February 12, 2026

Conditions
Prostate CancerProstate Cancer RecurrentProstate Cancer MetastaticMetastatic CancerOligometastasis
Interventions
DRUG

Darolutamide

600 mg BID

RADIATION

metastasis-directed treatment

stereotactic body radiotherapy

Trial Locations (8)

Unknown

RECRUITING

OLVZ Aalst, Aalst

RECRUITING

GZA, Antwerp

RECRUITING

AZ St-Jan Brugge, Bruges

RECRUITING

Institut Jules Bordet, Brussels

RECRUITING

AZ St-Lucas Gent, Ghent

RECRUITING

Ghent University Hospital, Ghent

RECRUITING

Jessa Ziekenhuis, Hasselt

RECRUITING

AZ Groeninge, Kortrijk

All Listed Sponsors
lead

University Hospital, Ghent

OTHER